BGR-34

From WikiMD's WELLNESSPEDIA

BGR-34 is an herbal medicine developed by the Council of Scientific and Industrial Research (CSIR) in India. It is marketed as an anti-diabetic drug and is claimed to help manage type 2 diabetes. The formulation is based on extracts from six medicinal plants, which are traditionally used in Ayurveda for their purported anti-diabetic properties.

Development and Composition[edit]

BGR-34 was developed by two CSIR laboratories, the Central Institute of Medicinal and Aromatic Plants (CIMAP) and the National Botanical Research Institute (NBRI). The formulation includes extracts from the following plants:

Mechanism of Action[edit]

The active ingredients in BGR-34 are believed to work by enhancing insulin secretion, improving insulin sensitivity, and reducing oxidative stress. These mechanisms help in the management of blood sugar levels in patients with type 2 diabetes.

Clinical Studies and Efficacy[edit]

The efficacy of BGR-34 has been evaluated in several clinical studies. These studies have shown that the formulation can help in reducing blood sugar levels and improving overall glycemic control. However, the scientific community has called for more extensive and rigorous clinical trials to validate these claims.

Usage and Dosage[edit]

BGR-34 is available in tablet form and is typically prescribed to be taken twice daily before meals. The dosage may vary based on the severity of the condition and the patient's response to the treatment.

Controversies and Criticisms[edit]

Despite its popularity, BGR-34 has faced criticism from some quarters. Critics argue that the claims of its efficacy are not sufficiently backed by large-scale clinical trials. There are also concerns about the standardization and quality control of herbal medicines.

See Also[edit]

References[edit]

External Links[edit]

Template:CSIR


This herbal medicine related article is a stub. You can help WikiMD by expanding it.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=BGR-34&oldid=5898666"